James J. Collins

a16z Podcast | All About Synthetic Biology

James J. Collins, Vijay Pande, Hanne Tidnam, Hannah, Jim Collins

Emerging from a late 1990s pivot by biomedical engineers seeking to reverse-engineer biological networks, synthetic biology was formally launched in 2000 following the breakthrough construction of a genetic toggle switch by Jim Collins' lab alongside a repressilator by Michael Elowitz and Stan Leibler. The discipline has since evolved from academic skepticism into a hybrid industry balancing rational engineering design with directed evolution and machine learning, ultimately transitioning from failed bioenergy hype to a sustainable focus on high-value biomedicine, therapeutics, and educational programs like BioBits. Looking forward, the field is poised to deliver transformative applications ranging from programmable living therapeutics to environmental solutions like carbon-sequestering algae, bridging the gap between theoretical biology and practical utility over the coming decades.